Understanding Your Pathology Report After Head and Neck Surgery

The pathology report arrives a few days after surgery. It is a dense, jargon-heavy document, usually two or three pages, and it contains information that will shape every treatment decision that follows. Most patients have never seen one before. The language — margins, lymphovascular invasion, extranodal extension, perineural invasion — is clinical shorthand that carries real weight, and trying to parse it alone, at home, the night before your follow-up appointment, is not a good experience.

I spend a significant portion of every post-operative visit going through the pathology report with my patients in detail. My goal is always the same: by the time you leave that appointment, you should understand what was found, what it means for your treatment, and why. This article is an attempt to give you a head start on that conversation.

The Basics: What the Report Is Telling You

A pathology report is the formal record of what the surgical pathologist found when examining the tissue removed during your operation. The pathologist is a physician who did not participate in your surgery — their job is to look at the tissue independently, using a combination of gross (naked eye) examination and microscopic analysis, and to describe what they see with precision.

The report will confirm the diagnosis — the specific type and grade of cancer — and then answer a series of questions about the tumor's characteristics and extent. These characteristics are not academic details. They directly inform whether you need additional treatment after surgery, and if so, what kind.

Surgical Margins

The surgical margin is one of the first things I look for in any pathology report. When a tumor is removed, the goal is to take the cancer out with a rim of normal tissue surrounding it — a clear margin. The pathologist examines the edges of the specimen and reports whether cancer cells are present at or near those edges.

Negative margins (also described as "clear" or "free" margins) mean that no cancer cells were identified at the edge of the specimen. This is the desired outcome.

Close margins mean that cancer cells were identified very near the edge — typically within one to two millimeters — but not at the edge itself. Close margins may warrant careful monitoring or additional treatment depending on the tumor site and other findings.

Positive margins mean that cancer cells extend to the cut edge of the specimen, indicating that some tumor may have been left behind. Positive margins are an important finding that often prompts additional surgery or radiation to address the residual disease.

It is worth understanding that margin assessment has inherent limitations. The pathologist samples representative sections of the specimen — they cannot examine every cell of every surface. And tissue changes size and shape after it is removed and processed. A reported close margin does not always mean that cancer remains; a reported negative margin does not guarantee that every microscopic cell was captured. These nuances are part of why pathology findings are interpreted in clinical context, not in isolation.

Lymph Node Status

In most head and neck cancers, one of the critical questions is whether the cancer has spread to the lymph nodes of the neck. The pathology report addresses this by examining every lymph node that was removed as part of your surgery and reporting how many nodes were found, and how many of those contained metastatic cancer.

The report will state something like "3 of 28 lymph nodes positive for metastatic squamous cell carcinoma." The total number of nodes removed, the number involved, and which levels of the neck (designated Level I through V) were affected all carry prognostic and treatment implications.

Extranodal extension (ENE) — sometimes called extracapsular spread — is an important additional finding. Under the microscope, cancer that has broken through the outer wall of a lymph node and grown into the surrounding soft tissue behaves more aggressively than cancer that remains contained within the node. The presence of extranodal extension is one of the strongest indications for concurrent chemotherapy with adjuvant radiation. It is a finding I discuss directly with patients because it frequently changes the post-operative treatment plan.

Perineural Invasion and Lymphovascular Invasion

These two findings describe how the cancer was growing at the microscopic level, and both are adverse prognostic features that influence treatment decisions.

Perineural invasion (PNI) means that cancer cells were found growing along or into nerves within the surgical specimen. Nerves can serve as a pathway for tumor spread, and perineural invasion is associated with higher rates of local recurrence. For certain tumors and sites, it is an indication for adjuvant radiation.

Lymphovascular invasion (LVI) means that cancer cells were identified within lymphatic channels or small blood vessels in the specimen. This suggests the cancer had the opportunity to disseminate before surgery, even if no lymph node metastases are identified. It is another factor that pathologists note and that oncologists weigh when making treatment recommendations.

Neither finding means that the surgery was unsuccessful or that cancer has definitely spread beyond what was removed. They are features of the tumor's biology that the treatment team uses to calibrate how aggressive the adjuvant plan should be.

HPV and p16 Status

For cancers of the oropharynx — the tonsils, base of tongue, soft palate, and posterior pharyngeal wall — HPV and p16 status are now routinely reported, and they matter a great deal.

HPV-positive oropharyngeal cancer (identified by p16 immunostaining as a surrogate marker) is a biologically distinct disease from HPV-negative cancer. It behaves less aggressively overall, carries a better prognosis, and is the subject of ongoing clinical trials exploring whether treatment intensity can be safely reduced. Knowing the HPV status of your tumor is essential for accurate staging under the current AJCC 8th edition system, which uses separate staging criteria for HPV-positive and HPV-negative oropharyngeal cancers.

For oral cavity cancers — lip, tongue, floor of mouth, gum, and hard palate — HPV testing is not routinely performed because HPV plays a much smaller role in these tumors.

Putting It Together: What Happens Next

After I review the pathology report, I present the findings at our multidisciplinary tumor board — a weekly conference where I review every case with radiation oncology, medical oncology, pathology, and radiology together. This is where the adjuvant treatment recommendation is made. The pathology findings are the primary input.

The most common scenario for patients with positive lymph nodes, positive or close margins, extranodal extension, or perineural invasion is a recommendation for adjuvant radiation therapy, sometimes with concurrent chemotherapy. The specific details of what is recommended — and whether that recommendation applies to you — depend on the totality of your pathology findings combined with your tumor's location, stage, and your overall health.

My goal in the post-operative visit is to make sure you understand not just what the report says, but why it leads to the recommendations being made. You should never leave my office with unanswered questions about your pathology results.

If you have questions about a recent diagnosis or pathology report and would like to discuss your case, I welcome new consultations. You can reach my office at 414-649-3920 to schedule an appointment.

---

Dr. Steven Sperry is a fellowship-trained head and neck surgeon specializing in head and neck cancer surgery and microvascular free flap reconstruction at Aurora St. Luke's Medical Center in Milwaukee, Wisconsin.